Cleveland Clinic European Society of Cardiology 2016 Symposium

Targeting Residual Cardiovascular Risk: Emerging Therapies and Novel Approaches

By Cleveland Clinic European Society of Cardiology 2016 Symposium
September 2016
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Houston Methodist DeBakey Heart and Vascular Center

Houston Heart Failure Summit 2020

Fri, Feb 7, 2020
Inova Heart and Vascular Institute 2020 Cherry Blossom Cardiovascular Symposium

2020 Inova Cherry Blossom Cardiovascular Symposium

Fri, Apr 24, 2020
25:31
Novartis

The War on Heart Failure

Feat. E. Braunwald
14:15
Scott Solomon

Angiotensin Receptor Neprilysin Inhibition for Heart Failure

07:24
25th Annual San Diego Heart Failure Symposium

ATTR Amyloidosis

07:16
Novartis

The Importance of Physical Examination in Patients With Heart Failure

Feat. G. Ewald
22:43
Mount Sinai Advanced Heart Symposium 2016

Chronic Heart Failure Update: Incorporating Sacubatril / Valsartan and I...

Feat. S. Pinney
07:57
Novartis

An Introduction to Heart Failure

Feat. J. Januzzi
19:50
Piedmont Heart Institute Napa Valley Cardiology Conference

Advanced Heart Failure: What Is It and When to Refer?

43:21
Novartis

Heart Failure from Bench to Bedside: The Role of Natriuretic Peptides

Feat. J. Burnett, J. Januzzi
19:25
Novartis

Biomarkers in Heart Failure

Feat. J. Januzzi
22:09
The 8th Annual International Hawaii Symposium on Diagnostic and Therapeutic Modalities in Heart Failure

Managing Side Effects and Drug-Drug Interactions in Heart Failure Patients

15:56
Cardiology Fiesta 2018

Update on New Pharmacological Therapy for Heart Failure

Feat. B. Bozkurt
23:33
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Treating Heart Failure Patients with ARNI’s – Why, When and How?

Feat. B. Greenberg
25:40
Novartis

The Role of the Kidneys in Heart Failure Progression

Feat. J. Diez
06:11
Novartis

Hospitalization: An Opportunity to Optimize Care for Patients with Heart...

Feat. J. Brown
09:00
Novartis

Diagnostic and Monitoring Tools and Tests in Heart Failure

Feat. W. Abraham
20:53
Northwestern Medicine: 3rd Annual Advances in Pulmonary Hypertension

Diagnosis and Management of Pulmonary Hypertension with HFpEF

Feat. S. Shah
14:01
Clyde Yancy

ACC/AHA/HFSA Update on New Pharmacological Therapy for Heart Failure

14:41
Cleveland Clinic Heart and Vascular Institute

Heart Failure Awareness

Feat. S. Nissen, R. Starling, J. Estep
13:31
James Januzzi

Ivabradine for Chronic Heart Failure

10:08
Novartis

Care Processes in the Hospitalized Patient with Heart Failure

Feat. G. Mentzer